Clinical trial
Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes
NCT00308737 · Mannkind Corporation, Industry · Completed
Key facts
| NCT number | NCT00308737 |
|---|---|
| Title | Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes |
| Official title | Pulmonary Outcomes Within a 2-Year Period in Subjects With Diabetes Mellitus Treated With Technosphere /Insulin or Usual Antidiabetic Treatment and in Subjects Without Abnormalities in Glucose Control. |
| Lead sponsor | Mannkind Corporation, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes, Type 1, Type 2 |
| Intervention type | Drug |
| Interventions | Technosphere® Insulin Inhalation Powder, Usual Care |
| Enrollment | 2,053 |
| Start date | Jun 1, 2005 |
| Primary completion | Sep 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Mar 30, 2006 |
| Last update posted | Oct 16, 2014 |
| Countries | Canada, Czechia, Poland, Russia, Spain, Ukraine, United Kingdom, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: